Ultrasound-guided minimally invasive interventions for refractory musculoskeletal pain: a real-world study from an interventional rheumatology unit. [PDF]
Paredes-Romero MB +15 more
europepmc +1 more source
Objectives To evaluate the impact of bimekizumab, a dual IL‐17A and IL‐17F inhibitor, on sacroiliac joint (SIJ) and spine inflammation/structural damage in axSpA using MRIs/radiographs from the phase 3 studies BE MOBILE 1 (nr‐axSpA) and 2 (r‐axSpA) and their open‐label extension (OLE).
Walter P. Maksymowych +10 more
wiley +1 more source
Myokine Signaling in Sarcopenia-Associated Chronic Musculoskeletal Pain: A Systematic Review of Inflammatory Mechanisms. [PDF]
Lee HS, Kim I, Kim JG, Kim YY.
europepmc +1 more source
Addendum: Managing Musculoskeletal Pain in Older Adults Through a Digital Care Solution: Secondary Analysis of a Prospective Clinical Study. [PDF]
Areias AC +8 more
europepmc +1 more source
Objective To examine the association between participation in a qualified clinical data registry and quality measure performance. Methods We included practices that joined the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) registry between 2015 – 2021.
Gabriela Schmajuk +5 more
wiley +1 more source
Effect of Fascial Distortion Model Treatment on Pain Intensity for Musculoskeletal Pain: A Systematic Review and Meta-Analysis. [PDF]
Ponce A +6 more
europepmc +1 more source
MDL‐800‐induced SIRT6 activation decreases age‐associated osteoarthritis in mice
Objective SIRT6 is a nuclear‐localized histone deacetylase that regulates multiple pathways associated with aging. This study aimed to determine whether systemic administration of a small molecule activator of SIRT6, MDL‐800, decreases the severity of age‐associated osteoarthritis (OA) in mice.
Matheus Moreira Perez +13 more
wiley +1 more source
Prevalence and associated factors of musculoskeletal pain among university students in Saudi Arabia: an analytical cross-sectional study. [PDF]
Alghamdi W.
europepmc +1 more source
Objectives The Assessment of SpondyloArthritis international Society recently defined early axial spondyloarthritis (axSpA) as a duration ≤2 years of axial symptoms. Previous studies have shown no significant difference in short‐term outcomes between early and established axSpA patients treated with biologic/targeted synthetic disease‐modifying anti ...
Annik Steimer +18 more
wiley +1 more source

